FcRn

Jan 17, 2025

Graves’ Disease Treatment Revolution: What’s Next in Line?

May 06, 2024

FcRn Inhibitors for Autoimmune Disorders: A Promising Therapeutic Approach

Sep 27, 2018

Ceribell raises $35M; Lyra reels $29.5M; Minoryx raises Euro21M; Alexion acquired Syntimmune

Newsletter/Whitepaper